Shreyas S. Kuduvalli
Puducherry, PY, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The synergistic anti-Warburg efficacy of temozolomide, metformin and epigallocatechin gallate in glioblastoma.
Journal: Toxicology and applied pharmacology
Published: August 30, 2024
Ultrastructural and immunohistochemical insights on the anti-glioma effects of a dual-drug cocktail in an in vivo experimental model.
Journal: Journal of chemotherapy (Florence, Italy)
Published: January 19, 2024
Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo.
Journal: Frontiers in pharmacology
Published: October 16, 2023
Unveiling the anti-glioma potential of a marine derivative, Fucoidan: its synergistic cytotoxicity with Temozolomide-an in vitro and in silico experimental study.
Journal: 3 Biotech
Published: March 30, 2023
Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma-induced xenograft model by modulating WNT/β-catenin signaling.
Journal: Fundamental & clinical pharmacology
Published: December 28, 2022
A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo.
Journal: Frontiers in pharmacology
Published: November 17, 2022
Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma- an in vitro and in vivo perspective.
Journal: Life sciences
Published: February 08, 2022
Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme.
Journal: Current molecular pharmacology
Published: October 24, 2020
Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond.
Journal: Cell biology international
Published: January 03, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026